申请人:Hanau E. Cathleen
公开号:US20080113971A1
公开(公告)日:2008-05-15
Compounds are described which inhibit mitogen activated protein kinase-activated protein kinase-2 (MK-2). Methods of making such compounds are described, as well as a method of using them for the inhibition of MK-2, and for the prevention or treatment of a disease or disorder that is mediated by TNFα, where the method involves administering to the subject an MK-2 inhibiting compound of the present invention. Pharmaceutical compositions and kits which contain the present MK-2 inhibiting compounds are also described.
本发明描述了一种抑制有丝分裂原活化蛋白激酶激活蛋白激酶-2(MK-2)的化合物。本发明还描述了制备这种化合物的方法,以及一种使用它们来抑制MK-2并预防或治疗由TNFα介导的疾病或障碍的方法,其中该方法涉及向受试者注射本发明的MK-2抑制化合物。本发明还描述了含有本MK-2抑制化合物的药物组合物和试剂盒。